Angiopoietin-2 is a crucial determinant of COVID-19 prognosis, study finds
![](./upload/news/image_1610992740_8470481.jpg)
A team of scientists from the United States and Sweden has recently demonstrated that increased levels of a proinflammatory cytokine, angiopoietin-2, is responsible for hypercoagulation observed in severe COVID-19 patients.